Interaction Between Drugs and the Gut Microbiome

Overview

Journal Gut

Specialty Gastroenterology

Date 2020 May 16

PMID 32409589

Citations 335

Authors

Rinse K Weersma

Alexandra Zhernakova

Jingyuan Fu

Affiliations

Soon will be listed here.

Abstract

The human gut microbiome is a complex ecosystem that can mediate the interaction of the human host with their environment. The interaction between gut microbes and commonly used non-antibiotic drugs is complex and bidirectional: gut microbiome composition can be influenced by drugs, but, vice versa, the gut microbiome can also influence an individual's response to a drug by enzymatically transforming the drug's structure and altering its bioavailability, bioactivity or toxicity (pharmacomicrobiomics). The gut microbiome can also indirectly impact an individual's response to immunotherapy in cancer treatment. In this review we discuss the bidirectional interactions between microbes and drugs, describe the changes in gut microbiota induced by commonly used non-antibiotic drugs, and their potential clinical consequences and summarise how the microbiome impacts drug effectiveness and its role in immunotherapy. Understanding how the microbiome metabolises drugs and reduces treatment efficacy will unlock the possibility of modulating the gut microbiome to improve treatment.

Citing Articles

Li D, Zhang K, Xue X, Bai Z, Yang L, Qi J Animals (Basel). 2025; 15(5).

PMID: 40076040 PMC: 11899446. DOI: 10.3390/ani15050755.

Gut-X axis.

Lin X, Yu Z, Liu Y, Li C, Hu H, Hu J Imeta. 2025; 4(1):e270.

PMID: 40027477 PMC: 11865426. DOI: 10.1002/imt2.270.

Gut Microbial Composition Is Associated with Symptom Self-Report in Trauma-Exposed Iraq and Afghanistan Veterans.

Li Y, Pagulayan K, Rau H, Hendrickson R, Schindler A Neurotrauma Rep. 2025; 6(1):1-12.

PMID: 40012717 PMC: 11850977. DOI: 10.1089/neur.2024.0011.

Alleviation of DSS-induced colitis by Meconopsis polysaccharides correlated with reduced PI3K/AKT signaling and gut microbiome diversity.

Dai J, Wang W, He F, Wang Y, Zou D Front Pharmacol. 2025; 16:1459668.

PMID: 40012624 PMC: 11861192. DOI: 10.3389/fphar.2025.1459668.

Bi-Directional Relationship Between Bile Acids (BAs) and Gut Microbiota (GM): UDCA/TUDCA, Probiotics, and Dietary Interventions in Elderly People.

Francini E, Badillo Pazmay G, Fumarola S, Procopio A, Olivieri F, Marchegiani F Int J Mol Sci. 2025; 26(4).

PMID: 40004221 PMC: 11855466. DOI: 10.3390/ijms26041759.

References

Crusell M, Hansen T, Nielsen T, Allin K, Ruhlemann M, Damm P . Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome. 2018; 6(1):89. PMC: 5952429. DOI: 10.1186/s40168-018-0472-x. View

Imhann F, Vich Vila A, Bonder M, Lopez Manosalva A, Koonen D, Fu J . The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017; 8(4):351-358. PMC: 5570416. DOI: 10.1080/19490976.2017.1284732. View

Nagata N, Tohya M, Fukuda S, Suda W, Nishijima S, Takeuchi F . Effects of bowel preparation on the human gut microbiome and metabolome. Sci Rep. 2019; 9(1):4042. PMC: 6411954. DOI: 10.1038/s41598-019-40182-9. View

Maini Rekdal V, Bess E, Bisanz J, Turnbaugh P, Balskus E . Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019; 364(6445). PMC: 7745125. DOI: 10.1126/science.aau6323. View

Zhernakova A, Kurilshikov A, Bonder M, Tigchelaar E, Schirmer M, Vatanen T . Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016; 352(6285):565-9. PMC: 5240844. DOI: 10.1126/science.aad3369. View

Vandeputte D, Falony G, Vieira-Silva S, Tito R, Joossens M, Raes J . Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2015; 65(1):57-62. PMC: 4717365. DOI: 10.1136/gutjnl-2015-309618. View

Sampson T, Debelius J, Thron T, Janssen S, Shastri G, Ilhan Z . Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016; 167(6):1469-1480.e12. PMC: 5718049. DOI: 10.1016/j.cell.2016.11.018. View

Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M . The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018; 359(6371):104-108. PMC: 6707353. DOI: 10.1126/science.aao3290. View

Frankel A, Coughlin L, Kim J, Froehlich T, Xie Y, Frenkel E . Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017; 19(10):848-855. PMC: 5602478. DOI: 10.1016/j.neo.2017.08.004. View

10.

Zhou W, Sailani M, Contrepois K, Zhou Y, Ahadi S, Leopold S . Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature. 2019; 569(7758):663-671. PMC: 6666404. DOI: 10.1038/s41586-019-1236-x. View

11.

Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman A . Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019; 570(7762):462-467. PMC: 6597290. DOI: 10.1038/s41586-019-1291-3. View

12.

Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman A . Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science. 2019; 363(6427). PMC: 6533120. DOI: 10.1126/science.aat9931. View

13.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson E . Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018; 555(7698):623-628. PMC: 6108420. DOI: 10.1038/nature25979. View

14.

Mallick H, Ma S, Franzosa E, Vatanen T, Morgan X, Huttenhower C . Experimental design and quantitative analysis of microbial community multiomics. Genome Biol. 2017; 18(1):228. PMC: 5708111. DOI: 10.1186/s13059-017-1359-z. View

15.

Baur D, Gladstone B, Burkert F, Carrara E, Foschi F, Dobele S . Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017; 17(9):990-1001. DOI: 10.1016/S1473-3099(17)30325-0. View

16.

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

17.

Leonard J, Marshall J, Moayyedi P . Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007; 102(9):2047-56. DOI: 10.1111/j.1572-0241.2007.01275.x. View

18.

Thomas A, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M . Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019; 25(4):667-678. PMC: 9533319. DOI: 10.1038/s41591-019-0405-7. View

19.

Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje A . Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020; 11(1):362. PMC: 6969170. DOI: 10.1038/s41467-019-14177-z. View

20.

Akram F, Huang Y, Lim V, Huggan P, Merchant R . Proton pump inhibitors: Are we still prescribing them without valid indications?. Australas Med J. 2015; 7(11):465-70. PMC: 4259212. DOI: 10.4066/AMJ.2014.2093. View